# Full list
List of studies included in survey paper on AI tools for diagnosis of prostate cancer

*By Uzair Shah, Hazrat Ali, and Zubair Shah*

[1]   Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.

[2]   Report by World Cancer Research Foundation, available at: https://www.wcrf.org/dietandcancer/prostate-cancer/ (Accessed: 25 August 2021)

[3]   N. Aldoj, et al., “Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network,” *Eur. Radiol.*, vol. 30, no. 2, pp. 1243–1253, 2020, doi: 10.1007/s00330-019-06417-z.

[4]   H. Bonkhoff, “[Gleason grading: diagnostic criteria and clinical implications].,” *Pathologe*, vol. 26, no. 6, pp. 422–432, Nov. 2005, doi: 10.1007/s00292-005-0793-y

[5]   I. Reda *et al.*, “A new CNN-based system for early diagnosis of prostate cancer,” *Proc. - Int. Symp. Biomed. Imaging*, vol. 2018-April, no. Isbi, pp. 207–210, 2018, doi: 10.1109/ISBI.2018.8363556

[6]   L. Pantanowitz *et al.*, “An artificial intelligence algorithm for prostate cancer diagnosis in whole slide images of core needle biopsies: a blinded clinical validation and deployment study,” *Lancet Digit. Heal.*, vol. 2, no. 8, pp. e407–e416, 2020, doi: 10.1016/S2589-7500(20)30159-X

[7]   L. Egevad *et al.*, “Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading,” *Virchows Arch.*, vol. 477, no. 6, pp. 777–786, 2020, doi: 10.1007/s00428-020-02858-w

[8]   S. A. Harmon, S. Tuncer, T. Sanford, P. L. Choyke, and B. Türkbey, “Artificial intelligence at the intersection of pathology and radiology in prostate cancer.,” *Diagn. Interv. Radiol.*, vol. 25, no. 3, pp. 183–188, May 2019, doi: 10.5152/dir.2019.19125

[9]   A. C. Tricco *et al.*, “PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation,” *Annals of Internal Medicine*, vol. 169, no. 7. American College of Physicians, pp. 467–473, Oct. 02, 2018, doi: 10.7326/M18-0850

[10]  J. Silva-Rodríguez, A. Colomer, and V. Naranjo, “WeGleNet: A weakly-supervised convolutional neural network for the semantic segmentation of Gleason grades in prostate histology images,” *Comput. Med. Imaging Graph.*, vol. 88, no. November 2020, 2021, doi: 10.1016/j.compmedimag.2020.101846

[11]  M. Lucas *et al.*, “Deep learning for automatic Gleason pattern classification for grade group determination of prostate biopsies,” *Virchows Arch.*, vol. 475, no. 1, pp. 77–83, 2019, doi: 10.1007/s00428-019-02577-x

[12]  J. Akatsuka *et al.*, “Illuminating clues of cancer buried in prostate MR image: Deep learning and expert approaches,” *Biomolecules*, vol. 9, no. 11, 2019, doi: 10.3390/biom9110673

[13]  Y. Feng *et al.*, “A Deep Learning Approach for Targeted Contrast-Enhanced Ultrasound Based Prostate Cancer Detection,” *IEEE/ACM Trans. Comput. Biol. Bioinforma.*, vol. 16, no. 6, pp. 1794–1801, 2019, doi: 10.1109/TCBB.2018.2835444

[14]  Z. Ma *et al.*, “Semantic segmentation for prostate cancer grading by convolutional neural networks,” no. March, p. 46, 2018, doi: 10.1117/12.2293000.

[15]  E. Arvaniti *et al.*, “Automated Gleason grading of prostate cancer tissue microarrays via deep learning,” *bioRxiv*, 2018, doi: 10.1101/280024

[16]  G. Kirlik *et al.*, “A Supervised Learning Tool for Prostate Cancer Foci Detection and Aggressiveness Identification using Multiparametric magnetic resonance imaging/magnetic resonance spectroscopy imaging,” *Cancer Inform.*, vol. 17, 2018, doi: 10.1177/1176935118786260

[17]  G. Wang, et al., “Diagnosis of prostate cancer in a Chinese population by using machine learning methods,” *Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. EMBS*, vol. 2018-July, pp. 1–4, 2018, doi: 10.1109/EMBC.2018.8513365

[18]  J. Ishioka *et al.*, “Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm,” *BJU Int.*, vol. 122, no. 3, pp. 411–417, 2018, doi: 10.1111/bju.14397

[19]  S. Kazemifar *et al.*, “Segmentation of the prostate and organs at risk in male pelvic CT images using deep learning,” *Biomed. Phys. Eng. Express*, vol. 4, no. 5, 2018, doi: 10.1088/2057-1976/aad100

[20]  Y. Song *et al.*, “Computer-aided diagnosis of prostate cancer using a deep convolutional neural network from multiparametric MRI,” *J. Magn. Reson. Imaging*, vol. 48, no. 6, pp. 1570–1577, 2018, doi: 10.1002/jmri.26047

[21]  J. Toivonen *et al.*, “Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization,” *PLoS One*, vol. 14, no. 7, pp. 1–23, 2019, doi: 10.1371/journal.pone.0217702

[22]  M. Truong *et al.*, “Multi-institutional Clinical Tool for Predicting High-risk Lesions on 3 Tesla Multiparametric Prostate Magnetic Resonance Imaging,” *Eur. Urol. Oncol.*, vol. 2, no. 3, pp. 257–264, 2019, doi: 10.1016/j.euo.2018.08.008

[23]  N. A. Parra *et al.*, “Habitats in dce-mri to predict clinically significant prostate cancers,” *Tomography*, vol. 5, no. 1, pp. 68–76, 2019, doi: 10.18383/j.tom.2018.00037

[24]  O. Kott *et al.*, “Development of a Deep Learning Algorithm for the Histopathologic Diagnosis and Gleason Grading of Prostate Cancer Biopsies: A Pilot Study,” *Eur. Urol. Focus*, pp. 2–6, 2019, doi: 10.1016/j.euf.2019.11.003

[25]  O. Hamzeh *et al.*, “A hierarchical machine learning model to discover gleason grade-specific biomarkers in prostate cancer,” *Diagnostics*, vol. 9, no. 4, 2019, doi: 10.3390/diagnostics9040219

[26]  S. Yoo, I. Gujrathi, M. A. Haider, and F. Khalvati, “Prostate Cancer Detection using Deep Convolutional Neural Networks,” *Sci. Rep.*, vol. 9, no. 1, pp. 1–10, 2019, doi: 10.1038/s41598-019-55972-4

[27]  A. Mehrtash *et al.*, “Automatic Needle Segmentation and Localization in MRI With 3-D Convolutional Neural Networks: Application to MRI-Targeted Prostate Biopsy.,” *IEEE Trans. Med. Imaging*, vol. 38, no. 4, pp. 1026–1036, Apr. 2019, doi: 10.1109/TMI.2018.2876796

[28]  T. Takeuchi, M. Hattori-Kato, Y. Okuno, S. Iwai, and K. Mikami, “Prediction of prostate cancer by deep learning with multilayer artificial neural network,” *Can. Urol. Assoc. J.*, vol. 13, no. 5, pp. E145–E150, 2019, doi: 10.5489/cuaj.5526

[29]  W. Bulten *et al.*, “Automated gleason grading of prostate biopsies using deep learning,” *arXiv*, pp. 1–13, 2019, doi: 10.1016/S1470-2045(19)30739-9

[30]  Y. Yuan *et al.*, “Prostate cancer classification with multiparametric MRI transfer learning model,” *Med. Phys.*, vol. 46, no. 2, pp. 756–765, 2019, doi: 10.1002/mp.13367

[31]  W. Li *et al.*, “Path R-CNN for Prostate Cancer Diagnosis and Gleason Grading of Histological Images.,” *IEEE Trans. Med. Imaging*, vol. 38, no. 4, pp. 945–954, Apr. 2019, doi: 10.1109/TMI.2018.2875868

[32]  B. Wang *et al.*, “Deeply supervised 3D fully convolutional networks with group dilated convolution for automatic MRI prostate segmentation,” *Med. Phys.*, vol. 46, no. 4, pp. 1707–1718, 2019, doi: https://doi.org/10.1002/mp.13416

[33]  B. Liu *et al.*, “Prediction of prostate cancer aggressiveness with a combination of radiomics and machine learning-based analysis of dynamic contrast-enhanced MRI,” *Clin. Radiol.*, vol. 74, no. 11, pp. 896.e1-896.e8, 2019, doi: 10.1016/j.crad.2019.07.011

[34]  B. Abraham and M. S. Nair, “Automated grading of prostate cancer using convolutional neural network and ordinal class classifier,” *Informatics Med. Unlocked*, vol. 17, p. 100256, 2019, doi: https://doi.org/10.1016/j.imu.2019.100256

[35]  C. Liu *et al.*, “Automatic Segmentation of the Prostate on CT Images Using Deep Neural Networks (DNN),” *Int. J. Radiat. Oncol. Biol. Phys.*, vol. 104, no. 4, pp. 924–932, 2019, doi: 10.1016/j.ijrobp.2019.03.017.

[36]  F. Zabihollahy, et al., “Automated segmentation of prostate zonal anatomy on T2-weighted (T2W) and apparent diffusion coefficient (ADC) map MR images using U-Nets,” *Med. Phys.*, vol. 46, no. 7, pp. 3078–3090, 2019, doi: 10.1002/mp.13550.

[37]  H. S. Ryu *et al.*, “Automated gleason scoring and tumor quantification in prostate core needle biopsy images using deep neural networks and its comparison with pathologist-based assessment,” *Cancers (Basel).*, vol. 11, no. 12, 2019, doi: 10.3390/cancers11121860

[38]  H. Xu, J. S. H. Baxter, O. Akin, and D. Cantor-Rivera, “Prostate cancer detection using residual networks.,” *Int. J. Comput. Assist. Radiol. Surg.*, vol. 14, no. 10, pp. 1647–1650, Oct. 2019, doi: 10.1007/s11548-019-01967-5.

[39]  D. Karimi, G. Nir, L. Fazli, P. C. Black, L. Goldenberg, and S. E. Salcudean, “Deep Learning-Based Gleason Grading of Prostate Cancer from Histopathology Images - Role of Multiscale Decision Aggregation and Data Augmentation,” *IEEE J. Biomed. Heal. Informatics*, vol. 24, no. 5, pp. 1413–1426, 2020, doi: 10.1109/JBHI.2019.2944643.

[40]  J. Suh *et al.*, “Development and validation of an explainable artificial intelligence-based decision-supporting tool for prostate biopsy,” *BJU Int.*, vol. 126, no. 6, pp. 694–703, 2020, doi: 10.1111/bju.15122

[41]  K. Nagpal *et al.*, “Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer from Biopsy Specimens,” *JAMA Oncol.*, vol. 6, no. 9, pp. 1372–1380, 2020, doi: 10.1001/jamaoncol.2020.2485.

[42]  L. Papp *et al.*, “Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI,” *Eur. J. Nucl. Med. Mol. Imaging*, 2020, doi: 10.1007/s00259-020-05140-y

[43]  M. Li *et al.*, “Radiomics prediction model for the improved diagnosis of clinically significant prostate cancer on biparametric MRI,” *Quant. Imaging Med. Surg.*, vol. 10, no. 2, pp. 368–379, 2020, doi: 10.21037/qims.2019.12.06.

[44]  M. Antonelli *et al.*, “Correction to: Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists (European Radiology, (2019), 29, 9, (4754-4764), 10.1007/s00330-019-06244-2),” *Eur. Radiol.*, vol. 30, no. 2, p. 1295, 2020, doi: 10.1007/s00330-019-06429-9

[45]  M. Arif *et al.*, “Clinically significant prostate cancer detection and segmentation in low-risk patients using a convolutional neural network on multi-parametric MRI,” *Eur. Radiol.*, vol. 30, no. 12, pp. 6582–6592, 2020, doi: 10.1007/s00330-020-07008-z

[46]  N. Orlando, D. J. Gillies, I. Gyacskov, C. Romagnoli, D. D’Souza, and A. Fenster, “Automatic prostate segmentation using deep learning on clinically diverse 3D transrectal ultrasound images,” *Med. Phys.*, vol. 47, no. 6, pp. 2413–2426, 2020, doi: 10.1002/mp.14134.

[47]  N. Gholizadeh *et al.*, “Voxel-based supervised machine learning of peripheral zone prostate cancer using noncontrast multiparametric MRI,” *J. Appl. Clin. Med. Phys.*, vol. 21, no. 10, pp. 179–191, 2020, doi: 10.1002/acm2.12992.

[48]  Z. Khan, N. Yahya, K. Alsaih, S. S. A. Ali, and F. Meriaudeau, “Evaluation of deep neural networks for semantic segmentation of prostate in T2W MRI,” *Sensors (Switzerland)*, vol. 20, no. 11, pp. 1–17, 2020, doi: 10.3390/s20113183.

[49]  P. H. Carroll and J. L. Mohler, “NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.,” *J. Natl. Compr. Canc. Netw.*, vol. 16, no. 5S, pp. 620–623, May 2018, doi: 10.6004/jnccn.2018.0036.

[50]  D. Kwon *et al.*, “Classification of suspicious lesions on prostate multiparametric MRI using machine learning.,” *J. Med. imaging (Bellingham, Wash.)*, vol. 5, no. 3, p. 34502, Jul. 2018, doi: 10.1117/1.JMI.5.3.034502

[51]  I. Reda *et al.*, “Deep learning role in early diagnosis of prostate cancer,” *Technol. Cancer Res. Treat.*, vol. 17, pp. 1–11, 2018, doi: 10.1177/1533034618775530

[52]  L. Hussain *et al.*, “Prostate cancer detection using machine learning techniques by employing combination of features extracting strategies,” *Cancer Biomark.*, vol. 21, no. 2, pp. 393–413, 2018, doi: 10.3233/CBM-170643.

[53]  K. Nagpal *et al.*, “Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer,” *npj Digit. Med.*, vol. 2, no. 1, 2019, doi: 10.1038/s41746-019-0112-2.

[54]  R. Alkadi, A. El-Baz, F. Taher, and N. Werghi, “A 2.5D deep learning-based approach for prostate cancer detection on T2-weighted magnetic resonance imaging,” *Lect. Notes Comput. Sci. (including Subser. Lect. Notes Artif. Intell. Lect. Notes Bioinformatics)*, vol. 11132 LNCS, pp. 734–739, 2019, doi: 10.1007/978-3-030-11018-5_66.

[55]  R. Cao *et al.*, “Joint Prostate Cancer Detection and Gleason Score Prediction in mp-MRI via FocalNet,” *IEEE Trans. Med. Imaging*, vol. 38, no. 11, pp. 2496–2506, 2019, doi: 10.1109/TMI.2019.2901928.

[56]  S. Nitta *et al.*, “Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity,” *Prostate Int.*, vol. 7, no. 3, pp. 114–118, 2019, doi: 10.1016/j.prnil.2019.01.001.

[57]  U. P. Poojitha and S. Lal Sharma, “Hybrid Unified Deep Learning Network for Highly Precise Gleason Grading of Prostate Cancer,” *Proc. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc. EMBS*, pp. 899–903, 2019, doi: 10.1109/EMBC.2019.8856912

[58]  C. Ntakolia, D. E. Diamantis, N. Papandrianos, S. Moustakidis, and E. I. Papageorgiou, “A Lightweight Convolutional Neural Network Architecture Applied for Bone Metastasis Classification in Nuclear Medicine: A Case Study on Prostate Cancer Patients,” *Healthcare*, vol. 8, no. 4, p. 493, 2020, doi: 10.3390/healthcare8040493.

[59]  D. J. Winkel, H. C. Breit, T. K. Block, D. T. Boll, and T. J. Heye, “High spatiotemporal resolution dynamic contrast-enhanced MRI improves the image-based discrimination of histopathology risk groups of peripheral zone prostate cancer: a supervised machine learning approach,” *Eur. Radiol.*, vol. 30, no. 9, pp. 4828–4837, 2020, doi: 10.1007/s00330-020-06849-y

[60]  G. A. Dominguez *et al.*, “Detecting Prostate Cancer Using Pattern Recognition Neural Networks With Flow Cytometry-Based Immunophenotyping in At-Risk Men,” *Biomark. Insights*, vol. 15, no. Ml, 2020, doi: 10.1177/1177271920913320.

[61]  M. S. Şerbănescu *et al.*, “Automated Gleason grading of prostate cancer using transfer learning from general-purpose deep-learning networks.,” *Rom. J. Morphol. Embryol. = Rev. Roum. Morphol. Embryol.*, vol. 61, no. 1, pp. 149–155, 2020, doi: 10.47162/RJME.61.1.17.

[62]  M. Islam, et al., “Deep learning approach for the development of a novel predictive model for prostate cancer,” *Stud. Health Technol. Inform.*, vol. 270, no. June, pp. 1241–1242, 2020, doi: 10.3233/SHTI200382.

[63]  S. Bernatz *et al.*, “Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features,” *Eur. Radiol.*, vol. 30, no. 12, pp. 6757–6769, 2020, doi: 10.1007/s00330-020-07064-5

[64]  G. García, A. Colomer, and V. Naranjo, “First-stage prostate cancer identification on histopathological images: Hand-driven versus automatic learning,” *Entropy*, vol. 21, no. 4, 2019, doi: 10.3390/e21040356.

[65]  A. A. Abbasi *et al.*, “Detecting prostate cancer using deep learning convolution neural network with transfer learning approach,” *Cogn. Neurodyn.*, vol. 14, no. 4, pp. 523–533, 2020, doi: 10.1007/s11571-020-09587-5.

[66]  F. Marginean *et al.*, “An Artificial Intelligence–based Support Tool for Automation and Standardisation of Gleason Grading in Prostate Biopsies,” *Eur. Urol. Focus*, vol. 46, no. 0, pp. 5–11, 2020, doi: 10.1016/j.euf.2020.11.001.

[67]  F. N. Jiang *et al.*, “The study of multiple diagnosis models of human prostate cancer based on Taylor database by artificial neural networks,” *J. Chinese Med. Assoc.*, vol. 83, no. 5, pp. 471–477, 2020, doi: 10.1097/JCMA.0000000000000299

[68]  H. Xu, S. Park, and T. H. Hwang, “Computerized Classification of Prostate Cancer Gleason Scores from Whole Slide Images,” *IEEE/ACM Trans. Comput. Biol. Bioinforma.*, vol. 17, no. 6, pp. 1871–1882, 2020, doi: 10.1109/TCBB.2019.2941195.

[69]  Y. Li *et al.*, “Automated Gleason Grading and Gleason Pattern Region Segmentation Based on Deep Learning for Pathological Images of Prostate Cancer,” *IEEE Access*, vol. 8, pp. 117714–117725, 2020, doi: 10.1109/ACCESS.2020.3005180.

[70]   Z. Tian et al., “Graph-convolutional-network-based interactive prostate segmentation in MR images,” Med. Phys., vol. 47, no. 9, pp. 4164–4176, 2020, doi: 10.1002/mp.14327.

[71]  J. J. Lee, et al., “Deep learning detection of prostate cancer recurrence with 18F-FACBC (fluciclovine, Axumin®) positron emission tomography,” Eur. J. Nucl. Med. Mol. Imaging, vol. 47, no. 13, pp. 2992–2997, 2020, doi: 10.1007/s00259-020-04912-w.
